ID   WAe009-A-13
AC   CVCL_UG29
SY   H9_RB1ex3_G12LS; G12LS; UDEe010-A-13
DR   BioSamples; SAMEA5912512
DR   hPSCreg; WAe009-A-13
DR   Wikidata; Q98134726
RX   PubMed=30312872;
CC   From: Universitat Duisburg-Essen; Duisburg; Germany.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; 9884; RB1 (Note=1 of 2 alleles).
CC   Sequence variation: Mutation; HGNC; 9884; RB1; Simple; p.Glu125Valfs*9 (c.374_380del); Zygosity=Heterozygous (PubMed=30312872).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9773 ! WA09
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 13-11-18; Last updated: 30-01-24; Version: 7
//
RX   PubMed=30312872; DOI=10.1016/j.scr.2018.09.016;
RA   Schipper L., Kanber D., Steenpass L.;
RT   "Generation of heterozygous and homozygous hESC H9 sublines carrying
RT   inactivating mutations in RB1.";
RL   Stem Cell Res. 33:41-45(2018).
//